Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 500,000 Shares

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 500,000 shares of the company on 12-11-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.5400 (-1.91%)
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 199,072 Shares

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 199,072 shares of the company on 11-29-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.5400 (-1.91%)
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

OPK : 1.5400 (-1.91%)
Opko Health (OPK) Q3 2024 Earnings Call Transcript

OPK earnings call for the period ending September 30, 2024.

OPK : 1.5400 (-1.91%)
OPKO Health: Q3 Earnings Snapshot

OPKO Health: Q3 Earnings Snapshot

OPK : 1.5400 (-1.91%)
OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

OPK : 1.5400 (-1.91%)
OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

OPK : 1.5400 (-1.91%)
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

OPK : 1.5400 (-1.91%)
Opko Health (OPK) Q2 2024 Earnings Call Transcript

OPK earnings call for the period ending June 30, 2024.

OPK : 1.5400 (-1.91%)
OPKO Health: Q2 Earnings Snapshot

OPKO Health: Q2 Earnings Snapshot

OPK : 1.5400 (-1.91%)

Barchart Exclusives

3 Highly-Rated Dividend Stocks To Buy on the Dip
Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar